Physician’s Profile

Vinayak N. Bapat, MD

Affiliations: 
NewYork-Presbyterian/Columbia
Board Certificates: 
Thoracic and Cardiac Surgery
Expertise: 
Mitral Valve Repair
Honors: 

European Association of Cardiothoracic Surgery. Techno-College Award for Innovation, 2013

About: 

I have just joined NewYork-Presbyterian Columbia University Medical Center (CUMC) in the field of cardiac and valve surgery and interventions. As Assistant Professor of Surgery at Columbia University Medical Center and Director, Transcatheter Valve Therapy in the Section of Cardiac Surgery, I am eager to advance care and bring innovative approaches to the treatment of heart disease, especially heart valve disease.

I come from a family of physicians and received my medical degree from Seth G.S. Medical School & King Edward VII Memorial Hospital, Mumbai, where I completed residencies in both general surgery and cardiothoracic surgery. During my residency, I continued to publish and present nationally and internationally. Throughout my training my area of interest was valve surgery and aortic surgery. In 1998, I received a fellowship at the Royal College of Surgeons in Edinburgh.

I was later appointed in Guys and St. Thomas’ Hospital, London as attending. Guys and St. Thomas’ is a world renowned and historical place. There, I specialized in complex valve surgery including infective endocarditis and reoperations, and in aortic surgery. I initiated in later years the aortic dissection service and we became the highest-volume dissection center in the UK. I also led the minimally invasive (key-hole) aortic valve replacement program (MIS) and pioneered the use of sutureless valves. In addition, I established the Anterior Right Thoracotomy (ART) approach for aortic valve replacement in the UK and have trained others in the UK, Europe and Asia in this approach.

Working at the forefront of Transcatheter Aortic Valve Replacement (TAVR) at Guys and St. Thomas’ Hospital which has the largest TAVR program in the UK, I developed new methods of performing TAVR which led to improved patient outcomes all over the world (transaortic approach). Further, I led the field in valve-in-valve therapy and have developed smartphone Apps to guide users in this procedure. The Apps are used by all TAVR users globally.

As a researcher, I have been involved in an early feasibility study of transcatheter mitral valve implantation (TMVR) and performed the first-in-man implant of Edwards’ FORTIS device (February 2014) and of Medtronic’s Intrepid device (2015). I am highly experienced in the use of TAVR devices in the mitral position, especially in complex scenarios. Currently, I sit on the advisory boards of numerous companies creating new mitral valve technologies, with a special interest in valve design and transcatheter mitral valve treatment.

Publications: 
Rajani R, Attia R, Condemi F, Webb J, Woodburn P, Hodson D, Nair A, Preston R, Razavi R, Bapat VN*. Multidector computed tomography sizing of bioprosthetic valves: guidelines for measurement and implications for valve-in-valve therapies. Clin Radiol 2016 Jan;71(1):e41-8. doi: 10.1016/j.crad.2015.10.013. Epub 2015 Nov 19.
Lucchese G, Rajani R, Patterson T, kapetanakis S, Redwood S, Bapat V*. Deloyed but not irretrievable: A novel surgical off-pump technique for parachute device extraction. Int J Cardiol 2016 Feb 1;204:66-9. doi: 10.1016/j.ijcard.2015.11.150. Epub 2015 Nov 23.
Vohra HA, Vaja R, Iakovakis I, Bapat V, Szostek J, Young C. Starting out in minimally invasive aortic valve replacement in the UK. Interact Cardiovasc Thorac Surg. 2016;22:104.
Condemi F, Bapat VN, Gianstefani S, Catibog N, Papachristidis A, Douiri A, Romea F, Monaghan MJ. Validation of Transesophageal Echocardiography n Vitro measurements for Bioprosthetic aortic valve: implications for percutaneous Valve-in-Valve therapy. J Am soc Echocardiogr 2015 Dec 19. pii: S0894-7317(15)00843-3. doi: 10.1016/j.echo.2015.11.002. [Epub ahead of print]
Bedair R, Morgan GJ, Bapat V, Kapetanakis S, Goreczny S, Simpson J, Quereshi SA. Early experience with the Occlutech PLD occlude for mitral paravalvar leak closure through a hybrid transapical approach. Eurointervention. 2015 Dec 23;11(8). pii: 20150419-01. doi: 10.4244/EIJY15M12_07. [Epub ahead of print]
Lim ZY, Boix R, Pendergast B, Rajani R, Redwood S, Hancock J, Young C, Bapat VN*. First reported case fo Transcatheter Mitral valve implantation in mitral annular calcification with a fully repositionable and self-expanding valve. Circ Cardiovasc Interv 2015 Nov;8(11). pii: e003031. doi: 10.1161/CIRCINTERVENTIONS.115.003031.
Bapat V, Asrress KN, Boix R, Lim ZY, Hancock J, Redwood SR. Transaortic transcatheter aortic valve implantation using Lotus valve: firat-in-man experience. Eurointervention 015 Nov 10;11(7). pii: 20141203-03. doi: 10.4244/EIJY15M11_03. [Epub ahead of print]
Noorani A, Radia R, Bapat V*. Challenges in valve-in-valve therapy. J Thorac Dis. 2015;7:1501-1508.
Bapat V, Pirone F, Kapetanakis S, Rajani R, Niederer S. Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1. Catheter Cardiovasc Interv. 2015;86:747-760.
Bapat V, Lim ZY, Boix R, Pirone F. The Edwards Fortis transcatheter mitral valve implantation system. EuroIntervention. 2015 Sep;11 Suppl W:W73-5.